Cancer Prevalence Trends in Kyrgyzstan (2020-2026): A Population-Based Epidemiologic Analysis
JCO Global Oncology · 2026-05 · 12 (5)
DOI: 10.1200/go-26-00137 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2026-05. Verfasst von Shafee Ur Rehman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Cancer represents a growing public health challenge in Kyrgyzstan, with increasing incidence and cumulative prevalence in recent years. This study aimed to evaluate national cancer prevalence and incidence trends in Kyrgyzstan between 2020 and 2026 and to assess epidemiologic patterns and public health implications. METHODS A population-based descriptive analysis was conducted using publicly available national oncology registry reports, Ministry of Health statistical publications, and international cancer databases. Annual incidence, prevalence, and crude incidence rates per 100,000 population were calculated using national demographic estimates. Temporal trends were evaluated using joinpoint regression modeling. RESULTS Annual newly diagnosed cancer cases increased from approximately 5,471 in 2020 to 6,651 in 2024. Crude incidence rates rose from 83 per 100,000 population in 2020 to more than 92 per 100,000 in 2024. National registry estimates indicate that over 35,000 individuals will be living with a cancer diagnosis by 2025. Stomach, breast, lung, cervical, and colorectal cancers accounted for the largest proportion of cases. A temporary stabilization in incidence was observed between 2022 and 2023, followed by an increase again in 2024. CONCLUSION Cancer burden in Kyrgyzstan increased steadily during the study period, with rising incidence and expanding national prevalence. These findings highlight the importance of strengthening national cancer surveillance systems, expanding screening programs, and improving oncology care infrastructure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Faculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan.
- Armed Forces Bone Marrow Transplant Center/National Institute of Blood and Marrow Transplant (AFBMTC/NIBMT), Rawalpindi, Pakistan.
ORCID-Profile: Shafee Ur Rehman
Zitieren
APA
Ur Rehman, S., & Ali, W. (2026). Cancer Prevalence Trends in Kyrgyzstan (2020-2026): A Population-Based Epidemiologic Analysis. JCO Global Oncology, 12(5). https://doi.org/10.1200/go-26-00137
Vancouver
Ur Rehman S, Ali W. Cancer Prevalence Trends in Kyrgyzstan (2020-2026): A Population-Based Epidemiologic Analysis. JCO Global Oncology. 2026;12(5). doi:10.1200/go-26-00137
BibTeX
@article{UrRehman2026,
author = {Ur Rehman, Shafee and Ali, Wajid},
title = {Cancer Prevalence Trends in Kyrgyzstan (2020-2026): A Population-Based Epidemiologic Analysis},
journal = {JCO Global Oncology},
year = {2026},
volume = {12},
number = {5},
doi = {10.1200/go-26-00137}
}
EUVIMED